ANTI-HSV ANTIBODY

The invention relates to an anti-HSV antibody as defined in the claims, a pharmaceutical composition comprising of an effective amount of the said antibody, an expression vector comprising of a nucleotide sequence which encodes the said antibody, a host cell comprising of the said nucleotide sequenc...

Full description

Saved in:
Bibliographic Details
Main Authors ROGGENDORF, Michael, KRAUSS, Jürgen, DÄUMER, Martin, ARNDT, Michaela, KRAWCZYK, Adalbert, EIS-HÜBINGER, Anna-Maria, EXNER, Evelyn, SCHNEWEIS, Karl Eduard
Format Patent
LanguageEnglish
French
German
Published 02.01.2019
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The invention relates to an anti-HSV antibody as defined in the claims, a pharmaceutical composition comprising of an effective amount of the said antibody, an expression vector comprising of a nucleotide sequence which encodes the said antibody, a host cell comprising of the said nucleotide sequence, a hybridoma cell capable of producing the said antibody and the use of the said antibody as a drug, in particular to use for the manufacture of a drug for the prophylactical or therapeutical treatment of HSV-associated diseases in a subject; as defined in the claims.
Bibliography:Application Number: EP20100765381